THE PROGNOSTIC/PREDICTIVE ROLE OF IDH1 GENE MUTATIONS IN PATIENTS TREATED FOR RECURRENT GLIOMA

被引：0
|
作者：
Lv, S. [1 ,2 ]
Sadones, J. [1 ,2 ]
Teugels, E. [1 ,2 ]
Huylebrouck, M. [1 ,2 ]
De Witte, O. [3 ]
Salmon, I. [4 ]
Michotte, A. [5 ]
De Greve, J. [1 ,2 ]
Neyns, B. [1 ,2 ]
机构：
[1] Vrije Univ Brussel, Mol Oncol Lab, Brussels, Belgium
[2] Vrije Univ Brussel, Dept Med Oncol, UZ Brussel, Brussels, Belgium
[3] ULB Erasme, Dept Neurosurg, Brussels, Belgium
[4] ULB Erasme, Dept Pathol, Brussels, Belgium
[5] Vrije Univ Brussel, Dept Pathol, UZ Brussel, Brussels, Belgium
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [31] CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS
    Peters, Katherine
    Lipp, Eric
    Broadwater, Gloria
    Herndon, James, II
    Johnson, Margaret
    Randazzo, Dina
    Desjardins, Annick
    Friedman, Henry
    Ashley, David
    Affronti, Mary
    NEURO-ONCOLOGY, 2020, 22 : 137 - 137
  • [32] AG120, A FIRST-IN-CLASS MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: RESULTS FROM THE PHASE 1 GLIOMA EXPANSION COHORTS
    Mellinghoff, Ingo K.
    Touat, Mehdi
    Maher, Elizabeth
    DeLaFuente, Macarena
    Cloughesy, Timothy F.
    Holdhoff, Matthias
    Cote, Gregory
    Burris, Howard
    Janku, Filip
    Huang, Raymond
    Young, Robert
    Ellingson, Benjamin
    Auer, Julia
    Liu, Hua
    Hurov, Jonathan
    Yen, Katherine
    Agresta, Sam
    Attar, Eyal
    Pandya, Susan
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2016, 18 : 12 - 12
  • [33] THE PROGNOSTIC ROLE OF IDH MUTATIONS IN HOMOGENEOUSLY TREATED PATIENTS WITH MALIGNANT DIFFUSE ASTROCYTOMAS
    Christians, Arne
    Banan, Rouzbeh
    Stockhammer, Florian
    Hartmann, Christian
    NEURO-ONCOLOGY, 2019, 21 : 145 - 145
  • [34] The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
    Christians, Arne
    Adel-Horowski, Antonia
    Banan, Rouzbeh
    Lehmann, Ulrich
    Bartels, Stephan
    Behling, Felix
    Barrantes-Freer, Alonso
    Stadelmann, Christine
    Rohde, Veit
    Stockhammer, Florian
    Hartmann, Christian
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [35] The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
    Arne Christians
    Antonia Adel-Horowski
    Rouzbeh Banan
    Ulrich Lehmann
    Stephan Bartels
    Felix Behling
    Alonso Barrantes-Freer
    Christine Stadelmann
    Veit Rohde
    Florian Stockhammer
    Christian Hartmann
    Acta Neuropathologica Communications, 7
  • [36] IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
    Nobusawa, Sumihito
    Watanabe, Takuya
    Kleihues, Paul
    Ohgaki, Hiroko
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6002 - 6007
  • [37] Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification
    Mehra, Rohit
    Shah, Tanmay
    Liu, Chia-Jen
    Plouffe, Komal R.
    Wang, Xiaoming
    Mannan, Rahul
    Cao, Xuhong
    Chinnaiyan, Arul M.
    Tomlins, Scott A.
    Udager, Aaron M.
    MODERN PATHOLOGY, 2023, 36 (06)
  • [38] A PERIOPERATIVE STUDY OF SAFUSIDENIB IN PATIENTS WITH IDH1 MUTATED GLIOMA
    Whittle, James
    Rosenthal, Mark
    Spiteri, Montana
    Tobler, Robert
    Topp, Monique
    Cain, Sarah
    Jones, Jordan
    Shaya, Sammy
    Valkovic, Adam
    Fatunla, Oluwaseun
    Dimou, James
    Roberts-Thomson, Samuel
    Mcardle, David
    Lui, Elaine
    Nijagal, Brunda
    Mitchell, Camilla
    Grimmond, Sean
    Best, Sarah
    Freytag, Saskia
    Drummond, Kate
    NEURO-ONCOLOGY, 2024, 26
  • [39] Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in glioma
    Jones, Jordan J.
    Nguyen, Hong
    Wong, Stephen Q.
    Whittle, James
    Iaria, Josie
    Stylli, Stanley
    Towner, James
    Pieters, Thomas
    Gaillard, Frank
    Kaye, Andrew H.
    Drummond, Katharine J.
    Morokoff, Andrew P.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [40] A perioperative study of safusidenib in patients with IDH1 mutated glioma
    Whittle, J. R.
    Rosenthal, M.
    Spiteri, M.
    Cain, S.
    Topp, M. D.
    Shaya, S.
    Jones, J.
    Valkovic, A.
    Fatunla, O.
    Dimou, J.
    Tobler, R.
    Roberts-Thomson, S.
    McArdle, D.
    Lui, E.
    Nijagal, B.
    Grimmond, S. M.
    Best, S. A.
    Freytag, S.
    Drummond, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S407 - S407
12345